Status
Conditions
Treatments
About
The purpose of this study is to evaluate the performance of DAILIES TOTAL1 daily disposable contact lenses with regards to subjective symptoms (comfort, dryness, vision) in lens wearers who use identify themselves as substantial digital device users (at least eight hours of digital device use per day).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Are participating in any concurrent clinical or research study involving intervention or invasive ocular tests;
Are presbyopic or habitually use a reading addition for close work;
Have any known active* ocular disease and/or infection; [* For the purposes of this study, active ocular disease is defined as infection or inflammation which requires therapeutic treatment. Mild (i.e. not considered clinically relevant) lid abnormalities (blepharitis, meibomian gland dysfunction, papillae), corneal and conjunctival staining and mild dry eye are not considered active ocular disease. Neovascularization and corneal scars are the result of previous hypoxia, infection or inflammation and are therefore not active.]
Meet the diagnosis of dry eye disease as per the following combination:
Meets the symptom criteria of Contact Lens Dry Eye Questionnaire (CLDEQ-8) score ≥12
And they show 1 of the following 2 signs:
Have a systemic condition that in the opinion of the investigator may affect a study outcome variable;+ [+ Any potential exclusion will be reviewed with the Lead Investigator or Principal Investigator prior to final decision making.]
Are using any systemic or topical medications that in the opinion of the investigator may affect a study outcome variable;
Are a current wearer of DAILIES TOTAL1® daily disposable contact lenses;
Have known sensitivity to the diagnostic pharmaceutical sodium fluorescein to be used in the study;
Have undergone refractive error surgery;
Are a member of the Centre for Ocular Research & Education (CORE) directly involved in the study.
Primary purpose
Allocation
Interventional model
Masking
41 participants in 1 patient group
Loading...
Central trial contact
Jill Woods, MSc, MCOptom
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal